Capstone Investment Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-400
| Closed | -$271K | – | 1708 |
|
|
2025
Q4 | $271K | Hold |
400
| – | – | ﹤0.01% | 1403 |
|
|
2025
Q3 | $256K | Buy |
+400
| New | +$243K | ﹤0.01% | 1712 |
|
|
2025
Q1 | – | Sell |
-2,200
| Closed | -$910K | – | 1601 |
|
|
2024
Q4 | $910K | Sell |
2,200
-4,700
| -68% | -$2.06M | ﹤0.01% | 1094 |
|
|
2024
Q3 | $3.49M | Hold |
6,900
| – | – | 0.01% | 569 |
|
|
2024
Q2 | $3.36M | Buy |
6,900
+4,500
| +188% | +$2.26M | 0.01% | 567 |
|
|
2024
Q1 | $1.3M | Hold |
2,400
| – | – | ﹤0.01% | 999 |
|
|
2023
Q4 | $1.33M | Sell |
2,400
-3,400
| -59% | -$1.6M | ﹤0.01% | 939 |
|
|
2023
Q3 | $2.54M | Buy |
5,800
+200
| +4% | +$99.7K | 0.01% | 644 |
|
|
2023
Q2 | $2.81M | Buy |
5,600
+200
| +4% | +$95.8K | 0.01% | 544 |
|
|
2023
Q1 | $2.7M | Buy |
5,400
+4,500
| +500% | +$2.15M | 0.01% | 512 |
|
|
2022
Q4 | $367K | Sell |
900
-9,000
| -91% | -$3.49M | ﹤0.01% | 1184 |
|
|
2022
Q3 | $3.23M | Buy |
9,900
+900
| +10% | +$331K | 0.02% | 551 |
|
|
2022
Q2 | $3.16M | Sell |
9,000
-3,500
| -28% | -$1.43M | 0.02% | 573 |
|
|
2022
Q1 | $6.84M | Buy |
12,500
+1,300
| +12% | +$684K | 0.02% | 598 |
|
|
2021
Q4 | $7.38M | Sell |
11,200
-22,900
| -67% | -$14.4M | 0.01% | 709 |
|
|
2021
Q3 | $21.2M | Buy |
34,100
+32,800
| +2,523% | +$22M | 0.04% | 411 |
|
|
2021
Q2 | $821K | Sell |
1,300
-24,800
| -95% | -$13.7M | ﹤0.01% | 1287 |
|
|
2021
Q1 | $12.8M | Buy |
26,100
+9,000
| +53% | +$4.51M | 0.04% | 400 |
|
|
2020
Q4 | $8.55M | Buy |
17,100
+900
| +6% | +$403K | 0.03% | 439 |
|
|
2020
Q3 | $6.37M | Buy |
16,200
+200
| +1% | +$73.9K | 0.03% | 448 |
|
|
2020
Q2 | $5.28M | Buy |
+16,000
| New | +$4.63M | 0.03% | 420 |
|
|
2020
Q1 | – | Sell |
-7,000
| Closed | -$1.83M | – | 1257 |
|
|
2019
Q4 | $1.83M | Sell |
7,000
-6,900
| -50% | -$1.82M | 0.01% | 855 |
|
|
2019
Q3 | $3.78M | Buy |
13,900
+5,800
| +72% | +$1.61M | 0.03% | 536 |
|
|
2019
Q2 | $2.23M | Buy |
8,100
+1,100
| +16% | +$271K | 0.02% | 705 |
|
|
2019
Q1 | $1.56M | Buy |
7,000
+3,400
| +94% | +$702K | 0.01% | 687 |
|
|
2018
Q4 | $670K | Buy |
3,600
+100
| +3% | +$20.5K | 0.01% | 740 |
|
|
2018
Q3 | $874K | Buy |
+3,500
| New | +$850K | 0.01% | 638 |
|
Other funds holding IDXX
VCM
VPM
Capstone Investment Advisors's IDXX Position: Q3 2025 in Review
Capstone Investment Advisors sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 2,310 shares — an estimated $1.4M sold.
Capstone Investment Advisors first reported a position in IDXX in Q2 2016 and held it in 18 quarters. The position peaked at $5.1M in Q1 2017. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.
- Capstone Investment Advisors reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
- Capstone Investment Advisors sold 2,310 Idexx Laboratories shares in Q3 2025, an estimated $1.4M.
- Capstone Investment Advisors first reported a position in Idexx Laboratories in Q2 2016 and held it in 18 quarters.
- Capstone Investment Advisors's Idexx Laboratories position peaked at $5.1M in Q1 2017.
- 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.
Based on Capstone Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.